DE68922822D1 - Verfahren und Vorrichtung zum Nachweis der periodischen weiblichen Unfruchtbarkeit. - Google Patents

Verfahren und Vorrichtung zum Nachweis der periodischen weiblichen Unfruchtbarkeit.

Info

Publication number
DE68922822D1
DE68922822D1 DE68922822T DE68922822T DE68922822D1 DE 68922822 D1 DE68922822 D1 DE 68922822D1 DE 68922822 T DE68922822 T DE 68922822T DE 68922822 T DE68922822 T DE 68922822T DE 68922822 D1 DE68922822 D1 DE 68922822D1
Authority
DE
Germany
Prior art keywords
menses
days
day
threshold value
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68922822T
Other languages
English (en)
Other versions
DE68922822T2 (de
Inventor
Thomas A Glaze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quidel Corp
Original Assignee
Quidel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quidel Corp filed Critical Quidel Corp
Application granted granted Critical
Publication of DE68922822D1 publication Critical patent/DE68922822D1/de
Publication of DE68922822T2 publication Critical patent/DE68922822T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/906—Fertility tests

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transplanting Machines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE68922822T 1988-11-04 1989-11-02 Verfahren und Vorrichtung zum Nachweis der periodischen weiblichen Unfruchtbarkeit. Expired - Fee Related DE68922822T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/267,148 US5118630A (en) 1988-11-04 1988-11-04 Method for determining periodic infertility in females

Publications (2)

Publication Number Publication Date
DE68922822D1 true DE68922822D1 (de) 1995-06-29
DE68922822T2 DE68922822T2 (de) 1995-12-07

Family

ID=23017523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68922822T Expired - Fee Related DE68922822T2 (de) 1988-11-04 1989-11-02 Verfahren und Vorrichtung zum Nachweis der periodischen weiblichen Unfruchtbarkeit.

Country Status (7)

Country Link
US (1) US5118630A (de)
EP (1) EP0367615B1 (de)
JP (1) JP3050389B2 (de)
AT (1) ATE123152T1 (de)
CA (1) CA1340210C (de)
DE (1) DE68922822T2 (de)
ES (1) ES2075853T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU759245B2 (en) * 1992-08-21 2003-04-10 Inverness Medical Switzerland Gmbh Monitoring method
GB9217864D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
GB9217866D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
GB9217808D0 (en) 1992-08-21 1992-10-07 Unilever Plc Advisory method
AU5631798A (en) * 1992-08-21 1998-05-21 Unipath Limited Monitoring method
GB9217865D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
ATE193430T1 (de) * 1993-07-02 2000-06-15 Unipath Ltd Testverfahren zur überwachung der fruchtbarkeitzustandes
US7141212B2 (en) 1993-11-12 2006-11-28 Inverness Medical Switzerland Gmbh Reading devices and assay devices for use therewith
AU1402295A (en) * 1993-12-16 1995-07-03 Abbott Laboratories Methods and means for determining the female fertile period
US5434057A (en) * 1994-02-02 1995-07-18 Quidel Corporation Sperm motility assay and devices
US6927064B1 (en) * 1994-06-29 2005-08-09 Inverness Medical Switzerland Gmbh Fertility computing method
US6451619B1 (en) 1994-06-29 2002-09-17 Inverness Medical Switzerland Gmbh Monitoring methods and devices for use therein
DE69626016T2 (de) 1996-09-27 2004-01-08 Inverness Medical Switzerland Gmbh Test-Kit und Vorrichtungen
DE69619236D1 (de) * 1996-09-27 2002-03-21 Unilever Plc Überwachungsverfahren
US6747917B2 (en) 2002-02-27 2004-06-08 Georgetown University Menstrual cycle monitor
JP4933258B2 (ja) 2003-09-22 2012-05-16 クイデル コーポレーション 試料中の複数分析物の検出装置
ES2640295T3 (es) 2005-04-04 2017-11-02 Biogen Ma Inc. Métodos para evaluar una respuesta inmune a un agente terapéutico
EP2676967B1 (de) 2006-02-28 2019-08-14 Biogen MA Inc. Verfahren zur Behandlung von Entzündungs- und Autoimmunerkrankungen mit Natalizumab
SG170058A1 (en) 2006-03-03 2011-04-29 Elan Pharm Inc Methods of treating inflammatory and autoimmune diseases with natalizumab
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
JP5214723B2 (ja) 2007-04-30 2013-06-19 ナノゲン・インコーポレイテッド 多分析物アッセイ
WO2008154813A1 (en) 2007-06-15 2008-12-24 Xiamen University Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
US9404911B2 (en) 2008-04-21 2016-08-02 Quidel Corporation Integrated assay device and housing
US8422740B2 (en) 2009-01-15 2013-04-16 Scott Dylewski Methods for determining a liquid front position on a test strip
US8692873B2 (en) 2009-01-15 2014-04-08 Alverix, Inc. Video-frame data receiver with low frame capture rate
EP3349010B1 (de) 2009-10-11 2024-08-28 Biogen MA Inc. Anti-vla-4-assays
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
CA2784137A1 (en) 2010-01-11 2011-07-14 Biogen Idec Ma Inc. Assay for jc virus antibodies
US10295472B2 (en) 2010-05-05 2019-05-21 Alverix, Inc. Assay reader operable to scan a test strip
FI3575792T3 (fi) 2011-05-31 2023-03-17 Pml-riskin arviointimenetelmä
US10119976B2 (en) 2013-05-28 2018-11-06 Biogen Ma Inc. Method of assessing risk of PML
FR3033410B1 (fr) 2015-03-06 2017-03-31 Laboratoire Hra-Pharma Dispositif pour l'identification de la periode infertile d'une femme
MX2018001353A (es) 2015-08-06 2018-05-22 Lia Diagnostics Inc Ensayos dispersables en agua.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH403345A (de) * 1959-07-13 1965-11-30 Wild Werner Verfahren zur Bestimmung der empfängnisfreien Tage bei der Frau sowie Mittel zur Durchführung des Verfahrens
GB1604863A (en) * 1978-05-31 1981-12-16 Hoechst Uk Ltd Progesterone radioimmunoassay
US4450239A (en) * 1981-09-23 1984-05-22 Northwestern University Method of determining pregnanediol in female urine and test device for use therein
USRE32557E (en) * 1981-09-23 1987-12-08 Northwestern University Method of determining pregnanediol in female urine and test device for use therein
IE54109B1 (en) * 1982-02-10 1989-06-21 Boots Celltech Diagnostics Assay
US4818677A (en) * 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application

Also Published As

Publication number Publication date
ES2075853T3 (es) 1995-10-16
EP0367615A2 (de) 1990-05-09
CA1340210C (en) 1998-12-15
DE68922822T2 (de) 1995-12-07
ATE123152T1 (de) 1995-06-15
EP0367615B1 (de) 1995-05-24
EP0367615A3 (de) 1991-11-27
JP3050389B2 (ja) 2000-06-12
JPH02164354A (ja) 1990-06-25
US5118630A (en) 1992-06-02

Similar Documents

Publication Publication Date Title
DE68922822D1 (de) Verfahren und Vorrichtung zum Nachweis der periodischen weiblichen Unfruchtbarkeit.
ATE148947T1 (de) Methoden zur empfängnisverhütung und test kits zu ihrer durchführung
FI950759A (fi) Tarkkailumenetelmä
DE69024677D1 (de) Verfahren und Vorrichtung zur Überwachung des Ovulationszyklus
DK0656119T3 (da) Overvågningsmetoder, anordninger og testsæt.
DE69402307D1 (de) Verfahren und vorrichtung zum ermitteln der schnellwerte des wahrnehmungsvermögens einer prüfperson für visuelle reize
BR9306939A (pt) Processo pra monitorar o estado de um ciclo de ovulação corrente de um sujeito individual do sexo feminino mamífero estojo de teste para conduzir o processo dispositivo eletrónico programado para uso no processo e pluralidade de dispositivos de teste de fluído corpóreo e de urina descartáveis
Cutler et al. Sporadic sexual behavior and menstrual cycle length in women
ES2148336T3 (es) Metodos destinados a determinar el estado de fertilidad.
FR2347428A1 (fr) Procede et dispositif de refroidissement rapide de coke, generateur de vapeur
Mulligan et al. Effects of induced anxiety states on electrodermal responding
JPS53142259A (en) Threshold condition testing system
Spitsin et al. In vitro testing the activity of Bordetella pertussis toxin on CHO cells.
FR2646339B1 (fr) Procede et dispositif de diagnostic et reeducation orthophoniques
SE8802505L (en) Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva
JPS53105333A (en) Device for and method of inspecting id card on line
JPS5432032A (en) Diagnosis/evaluation/test method for memory
IT8460980V0 (it) Metodo e dispositivo di sveglia con i quali si determina l'ottimizzazione della funzione di sveglia grazie alla rilevazione ed alla analisi del comportamento del soggetto, per cui solo l'effettivo abbandono del letto permette la disattivazione dell'allarme.
JPS5250280A (en) Tension testing method for rubber

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee